Longtime runner Annie Saunders didn’t let a 2021 diagnosis of multiple sclerosis sideline her passions. If anything, the 40-year-old Irwin native pushes harder — through weakness and imbalance caused ...
Pharmaceutical giant Pfizer has abandoned negotiations to have a breakthrough cancer drug listed on the Pharmaceutical ...
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of ocrelizumab for the treatment of ...
The company behind it intends to offer this treatment free of charge to eligible American patients. Read more at straitstimes ...
A groundbreaking and “life-changing” new million-dollar gene therapy has been given to a “butterfly” child for the first time ...
Dublin, April 13, 2026 (GLOBE NEWSWIRE)-- The "Multiple Sclerosis - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights on over ...
The company behind it intends to offer this treatment free of charge to eligible American patients. Read more at straitstimes ...
Over the past decade, InnoCare has achieved remarkable results. 2026 marks the beginning of the Company’s next golden decade of development. Driven by its outstanding performance in 2025, the Company ...
Inc. as its exclusive IPO advisor for a US$100 million Nasdaq IPO in Q2 2027. Advised by MAS Capital, Suntec is under discussion with VCs for a US$25 million Series A private placement, which the ...
US FDA approves Sanofi's Tzield to delay the onset of stage 3 type 1 diabetes in young children: Paris Friday, April 24, 2026, 11:00 Hrs [IST] The US Food and Drug Administration ...
Lovell Government Services and SetPoint Medical partner to deliver FDA-approved neuroimmune therapy for rheumatoid ...
Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young childrenExpanded approval includes children aged one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results